GRFS: Grifols 2019-02-07 12:31:00 Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System
Griffols is evolving in an ascending canal with 3 support level. The stock has drawn this week a very long hammer (10% length !) on the second support. Griffols has a very good behavior with long shadow hammer with only 1,6% of long shadow hammer not initiating bullish trends. We can predict a rebound in the coming weeks, with target the resistance of the canal...
GRFS: Grifols 2018-08-16 08:00:00 Grifols Achieves Key Milestone with FDA Approval of the New Consolidated Manufacturing Facility (CMF) for Production of Recombinant Proteins
Enter now at the flag break with stop below the LOD on the day of breakout